DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr | ₹-27 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR LAL PATHLABS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-83 Cr |
Mar2024 | ₹-42 Cr |
Mar2023 | ₹-37 Cr |
Mar2022 | ₹-33 Cr |
Mar2021 | ₹-27 Cr |
How is Deferred Tax Assets / Liabilities of DR LAL PATHLABS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-83 Cr | Negative | |
Mar2024 | ₹-42 Cr | Negative | |
Mar2023 | ₹-37 Cr | Negative | |
Mar2022 | ₹-33 Cr | Negative | |
Mar2021 | ₹-27 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹24,099.6 Cr | -2.7% | 1.4% | 5.7% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹112,954.0 Cr | -5.8% | 1.8% | 27.3% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹100,772.0 Cr | 0.2% | 0.3% | 11.6% | Stock Analytics | |
FORTIS HEALTHCARE | ₹56,504.8 Cr | -0.7% | 11.3% | 51.3% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹38,244.1 Cr | -2.2% | 7.5% | 53.9% | Stock Analytics | |
GLOBAL HEALTH | ₹31,245.2 Cr | -2.1% | -1.6% | -13.6% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -2.7% |
1.4% |
5.7% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses